Retractor maker EZ Surgical signs US distribution deal

The deal with Medline Industries can be estimated at tens of millions of dollars.

Ofer Hi Tech Ltd. portfolio company EZ Surgical Ltd. has signed a distribution deal with Medline Industries Inc., which EZ Surgical says is the largest private distributor of medical equipment in the US. Medline has 4,000 end points, including hospitals and private clinics.

Yokne'am-based EZ Surgical did not disclose the size of the deal, but it can be estimated at tens of millions of dollars. The company develops and produces surgical retractors: the Disposable Absorbent Secure Hold (DASH) retractor for open abdominal surgery, which has US Food and Drug Administration (FDA) clearance, and the new A-Lap 3D retractor/displacement laparoscopic procedures.

EZ Surgical CEO Tzur DiCori told "Globes", "Until now, we marketed our product independently in the US. We aimed to prove sales feasibility of the product. We showed that we could penetrate the product quickly at 150 hospitals, and that the sales turnover was short, only a few months."

EZ Surgical's sales team has moved on to market its latest product, the A-Lap.

DiCori added, "We're not building the company for sale, but for the long term." He added that he was considering an IPO for the company in two or three years. The company had $500,000 in sales last year, and DiCori predicts that the new deal will boost sales to $1.5 million.

Published by Globes [online], Israel business news - www.globes-online.com - on September 29, 2009

© Copyright of Globes Publisher Itonut (1983) Ltd. 2009

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Joseph Papa Perrigo up for sale

The pharmaceutical firm is seeking a merger at a premium on its $20 billion market cap.

Twitter Facebook Linkedin RSS Newsletters גלובס